[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-detail-339421-en":59,"doc-seo-339421-105":97},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":5,"data":60},{"doc_id":61,"user_id":62,"nickname":63,"user_avatar":64,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":66,"doc_content":67,"file_id":68,"file_url":69,"file_type":70,"file_size":71,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":46,"language":72,"language_code":73,"site_id":74,"html_lang":73,"table_of_contents":75,"faqs":76,"seo_title":77,"seo_description":66,"update_tm":78,"read_time":31,"preview_page_count":19,"preview_urls":79},339421,549758252649,"Ivy","https://ap-avatar.wpscdn.com/avatar/8000253669c5317157?_k=1778319167496531819","Plant-Based HSP90 Inhibitors in Breast Cancer Models - A Systematic Review","Breast cancer, the most invasive cancer in women globally, requires novel therapies due to continuing limits of current treatment options. Heat-shock protein 90 (HSP90), a chaperone protein involved in breast cancer pathogenesis, represents an attractive target. A systematic review (completed in January 2024) compiled in vitro, in vivo, and in silico studies assessing plant-based HSP90 inhibitors in breast cancer models. Eleven studies identified six plants and 24 compounds across six classes, showing dose- and time-dependent reductions in cell viability and antiproliferative activity with HSP90 inhibition. Extracts such as Tubocapsicum anomalum and other listed plants demonstrated the lowest IC50 values and effects on tumor growth, angiogenesis, and HSP90 expression and co-chaperone interactions, supporting further preclinical investigations.","Review  \nPlant-Based HSP90 Inhibitors in Breast Cancer Models: A Systematic Review  \nIlham Zarguan 1,*, Sonia Ghoul 2, Lamiae Belayachi 1 and Abdelaziz Benjouad 1  \nCitation: Zarguan, I.; Ghoul, S.; Belayachi, L.; Benjouad, A. PlantBased HSP90 Inhibitors in Breast Cancer Models: A Systematic Review. Int. J. Mol. Sci. 2024, 25, 5468 . [https://doi.org/10.3390/](https://doi.org/10.3390/)[ ](https://doi.org/10.3390/)ijms25105468  \nAcademic Editor: Daniela Grimm  \nReceived: 7 March 2024  \nRevised: 20 April 2024  \nAccepted: 24 April 2024  \nPublished: 17 May 2024  \nCopyright: © 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://](https://)[ ](https://)[creativecommons.org/licenses/by/](creativecommons.org/licenses/by/)[ ](creativecommons.org/licenses/by/)[4.0/](4.0/)) .  \n1 Center for Research on Health Sciences (CReSS), International Faculty of Medicine, College of Health Sciences, International University of Rabat, Technopolis Parc, Rocade of Rabat-Salé, Sala-Al Jadida 11100, Morocco; [lamiae.belayachi@uir.ac.ma](lamiae.belayachi@uir.ac.ma) (L.B.); [abdelaziz.benjouad@uir.ac.ma](abdelaziz.benjouad@uir.ac.ma) (A.B.)  \n2 Center for Research on Health Sciences (CReSS), International Faculty of Dental Medicine, College of Health Sciences, International University of Rabat, Technopolis Parc, Rocade of Rabat-Salé, Sala-Al Jadida 11100, Morocco; [sonia.ghoul@uir.ac.ma](sonia.ghoul@uir.ac.ma)  \n* Correspondence: [ilham.zarguan@uir.ac.ma](ilham.zarguan@uir.ac.ma); Tel.: +212-688-597-627  \nAbstract: Breast cancer, the most invasive cancer in women globally, necessitates novel treatments due to prevailing limitations of therapeutics. Search of news anticancer targets is more necessary than ever to tackle this pathology. Heat-Shock Protein 90 (HSP90), a chaperone protein, is implicated in breast cancer pathogenesis, rendering it an appealing target. Looking for alternative approach such as Plant-based compounds and natural HSP90 inhibitors offer promising prospects for innovative therapeutic strategies. This study aims to identify plant-based compounds with anticancer effects on breast cancer models and elucidate their mechanism of action in inhibiting the HSP90 protein. A systematic review was conducted and completed in January 2024 and included in vitro, in vivo, and in silico studies that investigated the effectiveness of plant-based HSP90 inhibitors tested on breast cancer models. Eleven studies were included in the review. Six plants and 24 compounds from six different classes were identified and proved to be effective against HSP90 in breast cancer models. The studied plant extracts showed a dose-and time-dependent decrease in cell viability. Variable IC50 values showed antiproliferative effects, with the plant Tubocapsicum anomalum demonstrating the lowest value. Withanolides was the most studied class. Fennel, Trianthema portulacastrum, and Spatholobus suberectus extracts were shown to inhibit tumor growth and angiogenesis and modulate HSP90 expression as well as its cochaperone interactions in breast cancer mouse models. The identified plant extracts and compounds were proven effective against HSP90 in breast cancer models, and this inhibition showed promising effects on breast cancer biology. Collectively, these results urge the need of further studies to better understand the mechanism of action of HSP90 inhibitors using comparable methods for preclinical observations.  \nKeywords: plant extracts; bioactive compounds; HSP90 heat-shock proteins; HSP90 inhibitors; breast neoplasms; breast cancer; systematic review  \n1. Introduction  \nThroughout history, natural products derived from plants have played a significant role in cancer therapy and medicine in general. Within the realm of natural products, small molecules synthesized by the plant kingdom have emerged as particularly promising ca","cbCaiv7bdbH3NZbq","https://ap.wps.com/l/cbCaiv7bdbH3NZbq","pdf",2050414,"English","en",105,"# Introduction\n# Review Methods and Search Strategy\n# Results: Plant-Based HSP90 Inhibitors\n## Identified Plants and Compound Classes\n## Effects on Cell Viability and IC50 Values\n## Modulation of HSP90, Angiogenesis, and Tumor Growth\n# Discussion\n# Conclusions and Future Directions","[{\"question\":\"What problem does the review address regarding breast cancer therapy?\",\"answer\":\"The review addresses the need for novel breast cancer treatments because prevailing therapeutic options have limitations. It focuses on discovering plant-based alternatives targeting HSP90.\"},{\"question\":\"Why is HSP90 considered an important target in breast cancer models?\",\"answer\":\"HSP90 is a chaperone protein implicated in breast cancer pathogenesis. Inhibiting HSP90 is expected to interfere with mechanisms supporting tumor biology.\"},{\"question\":\"What types of studies and model systems were included in the systematic review?\",\"answer\":\"The review included in vitro, in vivo, and in silico studies that evaluated plant-based HSP90 inhibitors in breast cancer models. A total of eleven studies were included.\"}]","Plant-Based HSP90 Inhibitors in Breast Cancer Models - A Systematic Review | PDF",1790030187,[80,84,88,93],{"page_no":8,"url":81,"width":82,"height":83},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a39788a81004c6a4b50b52faa033fd89.webp",983,1390,{"page_no":14,"url":85,"width":86,"height":87},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b454d5a1786a4cc7f0a55c6ae6ea0aea.webp",982,1388,{"page_no":89,"url":90,"width":91,"height":92},3,"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0e61f89d4c2f16d13fb8a5a3e8282554.webp",981,1387,{"page_no":19,"url":94,"width":95,"height":96},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d1ca07f3700f0de4143e8b8d6473f575.webp",980,1385,{"code":4,"msg":98,"data":99},"ok",{"site_id":74,"language":73,"slug":100,"title":65,"keywords":101,"description":66,"schema_data":102,"social_meta":155,"head_meta":157,"extra_data":159,"updated_unix":160},"plant-based-hsp90-inhibitors-in-breast-cancer-models-a-systematic-review","",{"@graph":103,"@context":154},[104,117,137],{"@type":105,"itemListElement":106},"BreadcrumbList",[107,111,113,115],{"item":108,"name":109,"@type":110,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":112,"name":9,"@type":110,"position":14},"https://docshare.wps.com/document/",{"item":114,"name":40,"@type":110,"position":89},"https://docshare.wps.com/document/research-report/",{"item":116,"name":65,"@type":110,"position":19},"https://docshare.wps.com/document/plant-based-hsp90-inhibitors-in-breast-cancer-models-a-systematic-review/339421/",{"url":116,"name":65,"@type":118,"image":119,"author":124,"headline":65,"publisher":126,"fileFormat":129,"inLanguage":73,"description":66,"dateModified":130,"datePublished":131,"encodingFormat":129,"isAccessibleForFree":132,"interactionStatistic":133},"DigitalDocument",{"url":120,"@type":121,"width":122,"height":123},"https://docshare.wps.com/thumbnails/plant-based-hsp90-inhibitors-in-breast-cancer-models-a-systematic-review/339421.png","ImageObject",300,407,{"name":63,"@type":125},"Person",{"url":108,"name":127,"@type":128},"DocShare","Organization","application/pdf","2026-11-07","2026-09-21",true,{"@type":134,"interactionType":135,"userInteractionCount":44},"InteractionCounter",{"@type":136},"ViewAction",{"@type":138,"mainEntity":139},"FAQPage",[140,146,150],{"name":141,"@type":142,"acceptedAnswer":143},"What problem does the review address regarding breast cancer therapy?","Question",{"text":144,"@type":145},"The review addresses the need for novel breast cancer treatments because prevailing therapeutic options have limitations. It focuses on discovering plant-based alternatives targeting HSP90.","Answer",{"name":147,"@type":142,"acceptedAnswer":148},"Why is HSP90 considered an important target in breast cancer models?",{"text":149,"@type":145},"HSP90 is a chaperone protein implicated in breast cancer pathogenesis. Inhibiting HSP90 is expected to interfere with mechanisms supporting tumor biology.",{"name":151,"@type":142,"acceptedAnswer":152},"What types of studies and model systems were included in the systematic review?",{"text":153,"@type":145},"The review included in vitro, in vivo, and in silico studies that evaluated plant-based HSP90 inhibitors in breast cancer models. A total of eleven studies were included.","https://schema.org",{"og:url":116,"og:type":156,"og:title":65,"og:site_name":127,"og:description":66},"article",{"robots":158,"canonical":116},"index,follow",{"doc_id":61,"site_id":74},1790817683]